Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Arezoo Sadoughi"'
Autor:
Mohsen Nabi-Afjadi, Morteza Heydari, Hamidreza Zalpoor, Ibrahim Arman, Arezoo Sadoughi, Parisa Sahami, Safiyeh Aghazadeh
Publikováno v:
Cellular & Molecular Biology Letters, Vol 27, Iss 1, Pp 1-25 (2022)
Abstract In nature, lectins are widely dispersed proteins that selectively recognize and bind to carbohydrates and glycoconjugates via reversible bonds at specific binding sites. Many viral diseases have been treated with lectins due to their wide ra
Externí odkaz:
https://doaj.org/article/bf0b410a6c424ac188600c08994a4975
Autor:
Reza Ramazani Khorshiddoust, Saleh Ramazani Khorshiddoust, Tahereh Hosseinabadi, Faezeh Mottaghitalab, Farzad Mokhtari, Fatemeh Azadinia, Hossein Mozdarani, Mohammad Shabani, Hamid Emadi-Kouchak, Bahram Taheri, Fatemeh Khani-Juyabad, Mina Amjadi Kashani, Arezoo Sadoughi, Sorour Zamanizadeh, Hadyeh Maddah, Maedeh Aminzadeh, Maryam Khanaki, Sabereh Saremi, Anahita Pashaee Rad, Ali Fatehi, Melika Ghaznavi Rad, Masoud Haftbaradaran, Mehran Khosroshahi, Mahtab Sadeghi, Majid Aminnayeri, Sirous Jafari, Fereshteh Ghiasvand, Arash Seifi, Sara Ghaderkhani, Seyed Ali Dehghan Manshadi, Mohammadreza Salehi, Ladan Abbasian, Malihe Hasannezhad, Mohsen Meidani, Mahboubeh Hajiabdolbaghi, Zahra Ahmadinejad, Masoud Parash, Zahra Sedighi, Abdorreza Mohammadian
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 149, Iss , Pp 112729- (2022)
Background: The scientific researches on COVID-19 pandemic topics are headed to an explosion of scientific literature. Despite these global efforts, the efficient treatment of patients is an in-progress challenge. Based on a meta-study of published s
Externí odkaz:
https://doaj.org/article/dce38244df71415888653aea9d55e33a
Autor:
Abbas Mirshafiey, Zahra Aghazadeh, Davod Sanaee Delir, Hamid Reza Gholamrezaie, Arezoo Sadoughi, Amir Nezami Asl, Mehran Noori Sanami, Armita Mahdavi Gorabi, Younes Panahi, Mahsa Taeb, Alireza Razavi, Sara Rafia, Zahra Naderiyan, Behrouz Robat-Jazi
Publikováno v:
Current Drug Discovery Technologies. 20
Introduction: Recently, the coronavirus disease 2019 (COVID-19) infection, with a vast spectrum of clinical and paraclinical symptoms has been a major health concern worldwide. Therapeutical management of COVID-19 includes antiviral and anti-inflamma
Autor:
Reza Ramazani Khorshiddoust, Saleh Ramazani Khorshiddoust, Tahereh Hosseinabadi, Faezeh Mottaghitalab, Farzad Mokhtari, Fatemeh Azadinia, Hossein Mozdarani, Mohammad Shabani, Hamid Emadi-Kouchak, Bahram Taheri, Fatemeh Khani-Juyabad, Mina Amjadi Kashani, Arezoo Sadoughi, Sorour Zamanizadeh, Hadyeh Maddah, Maedeh Aminzadeh, Maryam Khanaki, Sabereh Saremi, Anahita Pashaee Rad, Ali Fatehi, Melika Ghaznavi Rad, Masoud Haftbaradaran, Mehran Khosroshahi, Mahtab Sadeghi, Majid Aminnayeri, Sirous Jafari, Fereshteh Ghiasvand, Arash Seifi, Sara Ghaderkhani, Seyed Ali Dehghan Manshadi, Mohammadreza Salehi, Ladan Abbasian, Malihe Hasannezhad, Mohsen Meidani, Mahboubeh Hajiabdolbaghi, Zahra Ahmadinejad, Masoud Parash, Zahra Sedighi, Abdorreza Mohammadian
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 149
The scientific researches on COVID-19 pandemic topics are headed to an explosion of scientific literature. Despite these global efforts, the efficient treatment of patients is an in-progress challenge. Based on a meta-study of published shreds of evi
Publikováno v:
Drug development researchREFERENCES. 82(2)
Ankylosing spondylitis (AS) is a chronic autoimmune arthritis disease with a genetic background, affecting the skeletal axis, sacroiliac, and peripheral joints. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the first-line treatment for AS to alle
Autor:
Arman Ahmadzadeh, Zahra Rezaieyazdi, Bernd H. A. Rehm, Shazia Zamurrad, Hossein Soleymani-Salehabadi, Antimo D'Aniello, Hidenori Matsuo, Mostafa Hosseini, Seyed Shahabeddin Mortazavi-Jahromi, Zohreh Vahidi, Mandana Khodashahi, Abid Farooqi, Abbas Mirshafiey, Zahra Aghazadeh, Salvatore Cuzzocrea, Hossein Fallahzadeh, Arezoo Sadoughi, Mona Aslani, Saiedeh Omidian, Parvin Ekhtiari
Publikováno v:
Inflammopharmacology. 27(5)
The oral administration of drug β-d-mannuronic acid (M2000) showed a potent therapeutic effect in phase I/II study in rheumatoid arthritis (RA) patients. Here, our aim is to assess the efficacy and safety of this new drug in RA patients under a mult